2y1n › Citations

Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Dou H, Buetow L, Hock A, Sibbet GJ, Vousden KH, Huang DT
Nat Struct Mol Biol 19 184-92 (2012)
Related entries: 2y1m, 4a49, 4a4b, 4a4c

Cited: 117 times
EuropePMC logo PMID: 22266821

Abstract

Cbls are RING ubiquitin ligases that attenuate receptor tyrosine kinase (RTK) signal transduction. Cbl ubiquitination activity is stimulated by phosphorylation of a linker helix region (LHR) tyrosine residue. To elucidate the mechanism of activation, we determined the structures of human CBL, a CBL-substrate peptide complex and a phosphorylated-Tyr371-CBL-E2-substrate peptide complex, and we compared them with the known structure of a CBL-E2-substrate peptide complex. Structural and biochemical analyses show that CBL adopts an autoinhibited RING conformation, where the RING's E2-binding surface associates with CBL to reduce E2 affinity. Tyr371 phosphorylation activates CBL by inducing LHR conformational changes that eliminate autoinhibition, flip the RING domain and E2 into proximity of the substrate-binding site and transform the RING domain into an enhanced E2-binding module. This activation is required for RTK ubiquitination. Our results present a mechanism for regulation of c-Cbl's activity by autoinhibition and phosphorylation-induced activation.

Reviews - 2y1n mentioned but not cited (2)

  1. Macromolecular juggling by ubiquitylation enzymes. Lorenz S, Cantor AJ, Rape M, Kuriyan J. BMC Biol 11 65 (2013)
  2. Allosteric conformational barcodes direct signaling in the cell. Nussinov R, Ma B, Tsai CJ, Csermely P. Structure 21 1509-1521 (2013)

Articles - 2y1n mentioned but not cited (4)

  1. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Dou H, Buetow L, Hock A, Sibbet GJ, Vousden KH, Huang DT. Nat Struct Mol Biol 19 184-192 (2012)
  2. De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia. Hyrenius-Wittsten A, Pilheden M, Sturesson H, Hansson J, Walsh MP, Song G, Kazi JU, Liu J, Ramakrishan R, Garcia-Ruiz C, Nance S, Gupta P, Zhang J, Rönnstrand L, Hultquist A, Downing JR, Lindkvist-Petersson K, Paulsson K, Järås M, Gruber TA, Ma J, Hagström-Andersson AK. Nat Commun 9 1770 (2018)
  3. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. Li M, Kales SC, Ma K, Shoemaker BA, Crespo-Barreto J, Cangelosi AL, Lipkowitz S, Panchenko AR. Cancer Res 76 561-571 (2016)
  4. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)


Reviews citing this publication (35)

  1. Ubiquitin Ligases: Structure, Function, and Regulation. Zheng N, Shabek N. Annu Rev Biochem 86 129-157 (2017)
  2. New insights into ubiquitin E3 ligase mechanism. Berndsen CE, Wolberger C. Nat Struct Mol Biol 21 301-307 (2014)
  3. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Metzger MB, Pruneda JN, Klevit RE, Weissman AM. Biochim Biophys Acta 1843 47-60 (2014)
  4. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Buetow L, Huang DT. Nat Rev Mol Cell Biol 17 626-642 (2016)
  5. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Durcan TM, Fon EA. Genes Dev 29 989-999 (2015)
  6. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases. Mohapatra B, Ahmad G, Nadeau S, Zutshi N, An W, Scheffe S, Dong L, Feng D, Goetz B, Arya P, Bailey TA, Palermo N, Borgstahl GE, Natarajan A, Raja SM, Naramura M, Band V, Band H. Biochim Biophys Acta 1833 122-139 (2013)
  7. When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling. Nguyen LK, Kolch W, Kholodenko BN. Cell Commun Signal 11 52 (2013)
  8. Structural and functional insights to ubiquitin-like protein conjugation. Streich FC, Lima CD. Annu Rev Biophys 43 357-379 (2014)
  9. Physicochemical mechanisms of protein regulation by phosphorylation. Nishi H, Shaytan A, Panchenko AR. Front Genet 5 270 (2014)
  10. RBR E3-ligases at work. Smit JJ, Sixma TK. EMBO Rep 15 142-154 (2014)
  11. Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment. Liyasova MS, Ma K, Lipkowitz S. Clin Cancer Res 21 1789-1794 (2015)
  12. Degrons in cancer. Mészáros B, Kumar M, Gibson TJ, Uyar B, Dosztányi Z. Sci Signal 10 eaak9982 (2017)
  13. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Sévère N, Dieudonné FX, Marie PJ. Cell Death Dis 4 e463 (2013)
  14. Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies. Lucas X, Ciulli A. Curr Opin Struct Biol 44 101-110 (2017)
  15. Effect of posttranslational modifications on enzyme function and assembly. Ryšlavá H, Doubnerová V, Kavan D, Vaněk O. J Proteomics 92 80-109 (2013)
  16. Targeting HECT-type E3 ligases - insights from catalysis, regulation and inhibitors. Fajner V, Maspero E, Polo S. FEBS Lett 591 2636-2647 (2017)
  17. A broad view of scaffolding suggests that scaffolding proteins can actively control regulation and signaling of multienzyme complexes through allostery. Nussinov R, Ma B, Tsai CJ. Biochim Biophys Acta 1834 820-829 (2013)
  18. Activation of the E3 ubiquitin ligase Parkin. Caulfield TR, Fiesel FC, Springer W. Biochem Soc Trans 43 269-274 (2015)
  19. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Liu Q, Zhou H, Langdon WY, Zhang J. Cell Cycle 13 1875-1884 (2014)
  20. Specificity and disease in the ubiquitin system. Chaugule VK, Walden H. Biochem Soc Trans 44 212-227 (2016)
  21. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System. Guharoy M, Bhowmick P, Tompa P. J Biol Chem 291 6723-6731 (2016)
  22. Cell regulation by phosphotyrosine-targeted ubiquitin ligases. Cooper JA, Kaneko T, Li SS. Mol Cell Biol 35 1886-1897 (2015)
  23. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. Lyle CL, Belghasem M, Chitalia VC. Cells 8 E498 (2019)
  24. Signaling-mediated control of ubiquitin ligases in endocytosis. Polo S. BMC Biol 10 25 (2012)
  25. Force-Dependent Binding Constants. Wang Y, Yan J, Goult BT. Biochemistry 58 4696-4709 (2019)
  26. Ubiquitin ligases: guardians of mammalian development. Cruz Walma DA, Chen Z, Bullock AN, Yamada KM. Nat Rev Mol Cell Biol 23 350-367 (2022)
  27. The role of allostery in the ubiquitin-proteasome system. Liu J, Nussinov R. Crit Rev Biochem Mol Biol 48 89-97 (2013)
  28. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases. Celebi G, Kesim H, Ozer E, Kutlu O. Int J Mol Sci 21 E6335 (2020)
  29. Regulation of immune system development and function by Cbl-mediated ubiquitination. Li X, Gong L, Gu H. Immunol Rev 291 123-133 (2019)
  30. Towards the computational design of protein post-translational regulation. Strumillo M, Beltrao P. Bioorg Med Chem 23 2877-2882 (2015)
  31. Mutations of c-Cbl in myeloid malignancies. Katzav S, Schmitz ML. Oncotarget 6 10689-10696 (2015)
  32. Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road. Lacoursiere RE, Hadi D, Shaw GS. Biomolecules 12 467 (2022)
  33. Cbl-family proteins as regulators of cytoskeleton-dependent phenomena. Lee H, Tsygankov AY. J Cell Physiol 228 2285-2293 (2013)
  34. Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins. Park SS, Baek KH. Int J Mol Sci 23 514 (2022)
  35. Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications. George M, Masamba P, Iwalokun BA, Kappo AP. Am J Cancer Res 13 2773-2789 (2023)

Articles citing this publication (76)

  1. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT. Nat Struct Mol Biol 19 876-883 (2012)
  2. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Shi L, Wang Q, Li D, Wang J, Zheng P, Liu Y, Cao X. Cell 152 467-478 (2013)
  3. Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. DaRosa PA, Wang Z, Jiang X, Pruneda JN, Cong F, Klevit RE, Xu W. Nature 517 223-226 (2015)
  4. Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Scott DC, Sviderskiy VO, Monda JK, Lydeard JR, Cho SE, Harper JW, Schulman BA. Cell 157 1671-1684 (2014)
  5. Threshold-controlled ubiquitination of the EGFR directs receptor fate. Sigismund S, Algisi V, Nappo G, Conte A, Pascolutti R, Cuomo A, Bonaldi T, Argenzio E, Verhoef LG, Maspero E, Bianchi F, Capuani F, Ciliberto A, Polo S, Di Fiore PP. EMBO J 32 2140-2157 (2013)
  6. Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. Duda DM, Olszewski JL, Schuermann JP, Kurinov I, Miller DJ, Nourse A, Alpi AF, Schulman BA. Structure 21 1030-1041 (2013)
  7. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT. Nat Struct Mol Biol 20 982-986 (2013)
  8. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin. Caulfield TR, Fiesel FC, Moussaud-Lamodière EL, Dourado DF, Flores SC, Springer W. PLoS Comput Biol 10 e1003935 (2014)
  9. Hemi-methylated DNA regulates DNA methylation inheritance through allosteric activation of H3 ubiquitylation by UHRF1. Harrison JS, Cornett EM, Goldfarb D, DaRosa PA, Li ZM, Yan F, Dickson BM, Guo AH, Cantu DV, Kaustov L, Brown PJ, Arrowsmith CH, Erie DA, Major MB, Klevit RE, Krajewski K, Kuhlman B, Strahl BD, Rothbart SB. Elife 5 e17101 (2016)
  10. The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Mattiroli F, Uckelmann M, Sahtoe DD, van Dijk WJ, Sixma TK. Nat Commun 5 3291 (2014)
  11. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Johnson H, Del Rosario AM, Bryson BD, Schroeder MA, Sarkaria JN, White FM. Mol Cell Proteomics 11 1724-1740 (2012)
  12. Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface. Duda DM, Olszewski JL, Tron AE, Hammel M, Lambert LJ, Waddell MB, Mittag T, DeCaprio JA, Schulman BA. Mol Cell 47 371-382 (2012)
  13. Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation. Riling C, Kamadurai H, Kumar S, O'Leary CE, Wu KP, Manion EE, Ying M, Schulman BA, Oliver PM. J Biol Chem 290 23875-23887 (2015)
  14. Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells. Capuani F, Conte A, Argenzio E, Marchetti L, Priami C, Polo S, Di Fiore PP, Sigismund S, Ciliberto A. Nat Commun 6 7999 (2015)
  15. A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Gabrielsen M, Buetow L, Nakasone MA, Ahmed SF, Sibbet GJ, Smith BO, Zhang W, Sidhu SS, Huang DT. Mol Cell 68 456-470.e10 (2017)
  16. Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase activity. Wright JD, Mace PD, Day CL. Nat Struct Mol Biol 23 45-52 (2016)
  17. Changes in PUB22 Ubiquitination Modes Triggered by MITOGEN-ACTIVATED PROTEIN KINASE3 Dampen the Immune Response. Furlan G, Nakagami H, Eschen-Lippold L, Jiang X, Majovsky P, Kowarschik K, Hoehenwarter W, Lee J, Trujillo M. Plant Cell 29 726-745 (2017)
  18. Single-particle EM reveals extensive conformational variability of the Ltn1 E3 ligase. Lyumkis D, Doamekpor SK, Bengtson MH, Lee JW, Toro TB, Petroski MD, Lima CD, Potter CS, Carragher B, Joazeiro CA. Proc Natl Acad Sci U S A 110 1702-1707 (2013)
  19. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Lin L, Cao L, Liu Y, Wang K, Zhang X, Qin X, Zhao D, Hao J, Chang Y, Huang X, Liu B, Zhang J, Lu J, Ge Q. Leukemia 33 1475-1486 (2019)
  20. Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases. Chatrin C, Gabrielsen M, Buetow L, Nakasone MA, Ahmed SF, Sumpton D, Sibbet GJ, Smith BO, Huang DT. Sci Adv 6 eabc0418 (2020)
  21. Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer. Bhuripanyo K, Wang Y, Liu X, Zhou L, Liu R, Duong D, Zhao B, Bi Y, Zhou H, Chen G, Seyfried NT, Chazin WJ, Kiyokawa H, Yin J. Sci Adv 4 e1701393 (2018)
  22. c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth. Lyle C, Richards S, Yasuda K, Napoleon MA, Walker J, Arinze N, Belghasem M, Vellard I, Yin W, Ravid JD, Zavaro E, Amraei R, Francis J, Phatak U, Rifkin IR, Rahimi N, Chitalia VC. Sci Rep 9 20257 (2019)
  23. Functional diversity and structural disorder in the human ubiquitination pathway. Bhowmick P, Pancsa R, Guharoy M, Tompa P. PLoS One 8 e65443 (2013)
  24. Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation. Dou H, Duan Y, Zhang X, Yu Q, Di Q, Song Y, Li P, Gong Y. J Biol Chem 294 18504-18515 (2019)
  25. Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations. Martinelli S, Stellacci E, Pannone L, D'Agostino D, Consoli F, Lissewski C, Silvano M, Cencelli G, Lepri F, Maitz S, Pauli S, Rauch A, Zampino G, Selicorni A, Melançon S, Digilio MC, Gelb BD, De Luca A, Dallapiccola B, Zenker M, Tartaglia M. Hum Mutat 36 787-796 (2015)
  26. CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN. Javadi M, Richmond TD, Huang K, Barber DL. J Biol Chem 288 19459-19470 (2013)
  27. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy. Guey S, Grangeon L, Brunelle F, Bergametti F, Amiel J, Lyonnet S, Delaforge A, Arnould M, Desnous B, Bellesme C, Hervé D, Schwitalla JC, Kraemer M, Tournier-Lasserve E, Kossorotoff M. J Med Genet 54 550-557 (2017)
  28. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation. Kumaradevan S, Lee SY, Richards S, Lyle C, Zhao Q, Tapan U, Jiangliu Y, Ghumman S, Walker J, Belghasem M, Arinze N, Kuhnen A, Weinberg J, Francis J, Hartshorn K, Kolachalama VB, Cifuentes D, Rahimi N, Chitalia VC. Am J Pathol 188 1921-1933 (2018)
  29. article-commentary Cbl exposes its RING finger. Kales SC, Ryan PE, Lipkowitz S. Nat Struct Mol Biol 19 131-133 (2012)
  30. DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination. Ahmed SF, Buetow L, Gabrielsen M, Lilla S, Chatrin C, Sibbet GJ, Zanivan S, Huang DT. Sci Adv 6 eabc0629 (2020)
  31. Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation. Chung IC, Yuan SN, OuYang CN, Lin HC, Huang KY, Chen YJ, Chung AK, Chu CL, Ojcius DM, Chang YS, Chen LC. Cell Death Dis 9 1109 (2018)
  32. Scaffold Protein SLP-76 Primes PLCγ1 for Activation by ITK-Mediated Phosphorylation. Devkota S, Joseph RE, Min L, Bruce Fulton D, Andreotti AH. J Mol Biol 427 2734-2747 (2015)
  33. TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b. Chirino LM, Kumar S, Okumura M, Sterner DE, Mattern M, Butt TR, Kambayashi T. Eur J Immunol 50 48-55 (2020)
  34. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Pathak A, Pemov A, McMaster ML, Dewan R, Ravichandran S, Pak E, Dutra A, Lee HJ, Vogt A, Zhang X, Yeager M, Anderson S, Kirby M, NCI DCEG Cancer Genomics Research Laboratory, NCI DCEG Cancer Sequencing Working Group, Caporaso N, Greene MH, Goldin LR, Stewart DR. Hum Genet 134 775-787 (2015)
  35. Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain. Magnussen HM, Ahmed SF, Sibbet GJ, Hristova VA, Nomura K, Hock AK, Archibald LJ, Jamieson AG, Fushman D, Vousden KH, Weissman AM, Huang DT. Nat Commun 11 2094 (2020)
  36. Annotating Mutational Effects on Proteins and Protein Interactions: Designing Novel and Revisiting Existing Protocols. Li M, Goncearenco A, Panchenko AR. Methods Mol Biol 1550 235-260 (2017)
  37. Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins. Nadeau S, An W, Palermo N, Feng D, Ahmad G, Dong L, Borgstahl GE, Natarajan A, Naramura M, Band V, Band H. Biochem Anal Biochem Suppl 6 7921 (2012)
  38. Photocrosslinking Activity-Based Probes for Ubiquitin RING E3 Ligases. Mathur S, Fletcher AJ, Branigan E, Hay RT, Virdee S. Cell Chem Biol 27 74-82.e6 (2020)
  39. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK. Chang LC, Lin HY, Tsai MT, Chou RH, Lee FY, Teng CM, Hsieh MT, Hung HY, Huang LJ, Yu YL, Kuo SC. Br J Pharmacol 171 4010-4025 (2014)
  40. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis. Ahmad G, Mohapatra BC, Schulte NA, Nadeau SA, Luan H, Zutshi N, Tom E, Ortega-Cava C, Tu C, Sanada M, Ogawa S, Toews ML, Band V, Band H. Int J Biochem Cell Biol 57 123-134 (2014)
  41. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2. Anandapadamanaban M, Kyriakidis NC, Csizmók V, Wallenhammar A, Espinosa AC, Ahlner A, Round AR, Trewhella J, Moche M, Wahren-Herlenius M, Sunnerhagen M. J Biol Chem 294 11404-11419 (2019)
  42. Histone H2A variants alpha1-extension helix directs RNF168-mediated ubiquitination. Kelliher JL, West KL, Gong Q, Leung JWC. Nat Commun 11 2462 (2020)
  43. The RING-Type E3 Ligase XBAT35.2 Is Involved in Cell Death Induction and Pathogen Response. Liu H, Ravichandran S, Teh OK, McVey S, Lilley C, Teresinski HJ, Gonzalez-Ferrer C, Mullen RT, Hofius D, Prithiviraj B, Stone SL. Plant Physiol 175 1469-1483 (2017)
  44. Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells. Brian BF, Jolicoeur AS, Guerrero CR, Nunez MG, Sychev ZE, Hegre SA, Sætrom P, Habib N, Drake JM, Schwertfeger KL, Freedman TS. Elife 8 e46043 (2019)
  45. Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation. Buetow L, Tria G, Ahmed SF, Hock A, Dou H, Sibbet GJ, Svergun DI, Huang DT. BMC Biol 14 76 (2016)
  46. Mechanistic insight into how multidrug resistant Acinetobacter baumannii response regulator AdeR recognizes an intercistronic region. Wen Y, Ouyang Z, Yu Y, Zhou X, Pei Y, Devreese B, Higgins PG, Zheng F. Nucleic Acids Res 45 9773-9787 (2017)
  47. A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125. Bijlmakers MJ, Teixeira JM, Boer R, Mayzel M, Puig-Sàrries P, Karlsson G, Coll M, Pons M, Crosas B. Sci Rep 6 29232 (2016)
  48. Src inhibitors modulate frataxin protein levels. Cherubini F, Serio D, Guccini I, Fortuni S, Arcuri G, Condò I, Rufini A, Moiz S, Camerini S, Crescenzi M, Testi R, Malisan F. Hum Mol Genet 24 4296-4305 (2015)
  49. The Kinase Activity of Calcineurin B-like Interacting Protein Kinase 26 (CIPK26) Influences Its Own Stability and that of the ABA-regulated Ubiquitin Ligase, Keep on Going (KEG). Lyzenga WJ, Sullivan V, Liu H, Stone SL. Front Plant Sci 8 502 (2017)
  50. Cbl interacts with multiple E2s in vitro and in cells. Liyasova MS, Ma K, Voeller D, Ryan PE, Chen J, Klevit RE, Lipkowitz S. PLoS One 14 e0216967 (2019)
  51. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation. Mukhopadhyay C, Triplett A, Bargar T, Heckman C, Wagner KU, Naramura M. Proc Natl Acad Sci U S A 113 E8228-E8237 (2016)
  52. Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix. Xu Y, Yao B, Shi K, Lu J, Jin Y, Qi B, Li H, Pan S, Chen L, Ma C. FEBS Lett 589 857-864 (2015)
  53. article-commentary Structural biology: A protein engagement RING. Lima CD, Schulman BA. Nature 489 43-44 (2012)
  54. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis. Ahmed SF, Buetow L, Gabrielsen M, Lilla S, Sibbet GJ, Sumpton D, Zanivan S, Hedley A, Clark W, Huang DT. Oncogene 40 2149-2164 (2021)
  55. Functional 3D architecture in an intrinsically disordered E3 ligase domain facilitates ubiquitin transfer. Murphy P, Xu Y, Rouse SL, Jaffray EG, Plechanovová A, Matthews SJ, Carlos Penedo J, Hay RT. Nat Commun 11 3807 (2020)
  56. Loss of function Cbl-c mutations in solid tumors. Daniels SR, Liyasova M, Kales SC, Nau MM, Ryan PE, Green JE, Lipkowitz S. PLoS One 14 e0219143 (2019)
  57. Structure of UBE2K-Ub/E3/polyUb reveals mechanisms of K48-linked Ub chain extension. Nakasone MA, Majorek KA, Gabrielsen M, Sibbet GJ, Smith BO, Huang DT. Nat Chem Biol 18 422-431 (2022)
  58. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck MD, Meza J, Sheinin Y, Band V, Band H. Oncotarget 7 51107-51123 (2016)
  59. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome. Sun J, Liu Y, Zhu G, Cato C, Hao X, Qian L, Lin W, Adhikari R, Luo Y, Baudry M, Bi X. Sci Rep 10 9824 (2020)
  60. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor. Rodriguez S, Huynh-Do U. FASEB J 27 632-644 (2013)
  61. Phosphorylation control of the ubiquitin ligase Cbl is conserved in choanoflagellates. Amacher JF, Hobbs HT, Cantor AC, Shah L, Rivero MJ, Mulchand SA, Kuriyan J. Protein Sci 27 923-932 (2018)
  62. Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia. Martini V, Frezzato F, Severin F, Raggi F, Trimarco V, Martinello L, Molfetta R, Visentin A, Facco M, Semenzato G, Paolini R, Trentin L. Oncotarget 9 32219-32231 (2018)
  63. Phosphorylation of deinococcal RecA affects its structural and functional dynamics implicated for its roles in radioresistance of Deinococcus radiodurans. Sharma DK, Siddiqui MQ, Gadewal N, Choudhary RK, Varma AK, Misra HS, Rajpurohit YS. J Biomol Struct Dyn 38 114-123 (2020)
  64. Depletion of Csk preferentially reduces the protein level of LynA in a Cbl-dependent manner in cancer cells. Kuga T, Yamane Y, Hayashi S, Taniguchi M, Yamaguchi N, Yamagishi N. Sci Rep 10 7621 (2020)
  65. Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma. Li P, Liu H, Zhang Z, Lv X, Wang H, Ma J, Ma Z, Qu X, Teng YE. Med Sci Monit 24 623-635 (2018)
  66. Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation. Richards S, Walker J, Nakanishi M, Belghasem M, Lyle C, Arinze N, Napoleon MA, Ravid JD, Crossland N, Zhao Q, Rosenberg D, Rahimi N, Chitalia VC. Am J Pathol 190 602-613 (2020)
  67. Mapping regions in Ste5 that support Msn5-dependent and -independent nuclear export. Hu Z, Wang Y, Yu L, Mahanty SK, Mendoza N, Elion EA. Biochem Cell Biol 94 109-128 (2016)
  68. PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371. Chen H, Bai Y, Kobayashi M, Xiao S, Cai W, Barajas S, Chen S, Miao J, Meke FN, Vemula S, Ropa JP, Croop JM, Boswell HS, Wan J, Jia Y, Liu H, Li LS, Altman JK, Eklund EA, Ji P, Tong W, Band H, Huang DT, Platanias LC, Zhang ZY, Liu Y. Blood 141 244-259 (2023)
  69. Spatial features of proteins related to their phosphorylation and associated structural changes. Karasev DA, Veselova DA, Veselovsky AV, Sobolev BN, Zgoda VG, Archakov AI. Proteins 86 13-20 (2018)
  70. Assessing the Direct Binding of Ark-Like E3 RING Ligases to Ubiquitin and Its Implication on Their Protein Interaction Network. Mintis DG, Chasapi A, Poulas K, Lagoumintzis G, Chasapis CT. Molecules 25 E4787 (2020)
  71. The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia. Amhaz S, Boëda B, Chouchène M, Colasse S, Dingli F, Loew D, Henri J, Prunier C, Levy L. BMC Biol 21 73 (2023)
  72. The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Kimani SW, Perveen S, Szewezyk M, Zeng H, Dong A, Li F, Ghiabi P, Li Y, Chau I, Arrowsmith CH, Barsyte-Lovejoy D, Santhakumar V, Vedadi M, Halabelian L. Commun Biol 6 1272 (2023)
  73. The structure of the cysteine-rich region from human histone-lysine N-methyltransferase EHMT2 (G9a). Kerchner KM, Mou TC, Sun Y, Rusnac DV, Sprang SR, Briknarová K. J Struct Biol X 5 100050 (2021)
  74. What a difference a phosphate makes: life or death decided by a single amino acid in MDM2. Li YC, Wahl GM. Cancer Cell 21 595-596 (2012)
  75. Adipose-specific deletion of the cation channel TRPM7 inhibits TAK1 kinase-dependent inflammation and obesity in male mice. Zhong W, Ma M, Xie J, Huang C, Li X, Gao M. Nat Commun 14 491 (2023)
  76. Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity. Boerth JA, Chinn AJ, Schimpl M, Bommakanti G, Chan C, Code EL, Giblin KA, Gohlke A, Hansel CS, Jin M, Kavanagh SL, Lamb ML, Lane JS, Larner CJB, Mfuh AM, Moore RK, Puri T, Quinn TR, Ye M, Robbins KJ, Gancedo-Rodrigo M, Tang H, Walsh J, Ware J, Wrigley GL, Reddy IK, Zhang Y, Grimster NP. ACS Med Chem Lett 14 1848-1856 (2023)


Quick links